Morgan Stanley’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.6M Buy
1,192,606
+157,992
+15% +$1.4M ﹤0.01% 3392
2025
Q1
$8.1M Sell
1,034,614
-174,782
-14% -$1.37M ﹤0.01% 3532
2024
Q4
$12.7M Buy
1,209,396
+260,992
+28% +$2.74M ﹤0.01% 3186
2024
Q3
$12.4M Buy
948,404
+115,092
+14% +$1.51M ﹤0.01% 3254
2024
Q2
$11.7M Buy
833,312
+167,901
+25% +$2.36M ﹤0.01% 3195
2024
Q1
$11.2M Sell
665,411
-1,318,583
-66% -$22.3M ﹤0.01% 3256
2023
Q4
$28M Buy
1,983,994
+1,546,938
+354% +$21.8M ﹤0.01% 3044
2023
Q3
$4.5M Sell
437,056
-24,038
-5% -$248K ﹤0.01% 3831
2023
Q2
$7.6M Buy
461,094
+115,383
+33% +$1.9M ﹤0.01% 3432
2023
Q1
$3.17M Sell
345,711
-1,609
-0.5% -$14.7K ﹤0.01% 4140
2022
Q4
$2.49M Buy
347,320
+468
+0.1% +$3.35K ﹤0.01% 4317
2022
Q3
$1.74M Buy
346,852
+30,491
+10% +$153K ﹤0.01% 4532
2022
Q2
$772K Sell
316,361
-26,648
-8% -$65K ﹤0.01% 5184
2022
Q1
$2.34M Sell
343,009
-114,255
-25% -$780K ﹤0.01% 4394
2021
Q4
$3.69M Buy
457,264
+33,044
+8% +$267K ﹤0.01% 4035
2021
Q3
$4.16M Buy
424,220
+47,955
+13% +$470K ﹤0.01% 3930
2021
Q2
$2.53M Buy
376,265
+152,186
+68% +$1.02M ﹤0.01% 4455
2021
Q1
$2.03M Buy
224,079
+5,774
+3% +$52.2K ﹤0.01% 4248
2020
Q4
$1.46M Sell
218,305
-114,161
-34% -$762K ﹤0.01% 4413
2020
Q3
$1.68M Buy
332,466
+189,550
+133% +$956K ﹤0.01% 3810
2020
Q2
$1.16M Sell
142,916
-22,672
-14% -$183K ﹤0.01% 4061
2020
Q1
$1.31M Sell
165,588
-563,701
-77% -$4.47M ﹤0.01% 3732
2019
Q4
$5.51M Sell
729,289
-11,207
-2% -$84.6K ﹤0.01% 3103
2019
Q3
$3.08M Buy
740,496
+22,595
+3% +$94K ﹤0.01% 3395
2019
Q2
$2.08M Buy
717,901
+5,243
+0.7% +$15.2K ﹤0.01% 3744
2019
Q1
$1.03M Sell
712,658
-9,361
-1% -$13.5K ﹤0.01% 4094
2018
Q4
$1.86M Sell
722,019
-55,253
-7% -$143K ﹤0.01% 3832
2018
Q3
$3.41M Buy
777,272
+295,036
+61% +$1.3M ﹤0.01% 3565
2018
Q2
$2.96M Sell
482,236
-649,101
-57% -$3.98M ﹤0.01% 3709
2018
Q1
$8.25M Sell
1,131,337
-429,402
-28% -$3.13M ﹤0.01% 2526
2017
Q4
$12.8M Buy
1,560,739
+58,313
+4% +$478K ﹤0.01% 2145
2017
Q3
$15.8M Sell
1,502,426
-69,071
-4% -$725K ﹤0.01% 1811
2017
Q2
$17.3M Buy
1,571,497
+279,051
+22% +$3.08M 0.01% 1657
2017
Q1
$12.5M Buy
1,292,446
+79,913
+7% +$774K ﹤0.01% 1987
2016
Q4
$12.6M Buy
1,212,533
+109,039
+10% +$1.13M ﹤0.01% 2008
2016
Q3
$13.7M Buy
1,103,494
+168,772
+18% +$2.09M ﹤0.01% 1755
2016
Q2
$10M Buy
934,722
+145,834
+18% +$1.57M ﹤0.01% 1980
2016
Q1
$8.71M Buy
788,888
+69,425
+10% +$766K ﹤0.01% 1980
2015
Q4
$8.79M Buy
719,463
+408,531
+131% +$4.99M ﹤0.01% 2099
2015
Q3
$5.07M Buy
310,932
+44,554
+17% +$727K ﹤0.01% 2647
2015
Q2
$5.64M Buy
266,378
+160,429
+151% +$3.4M ﹤0.01% 2682
2015
Q1
$1.91M Sell
105,949
-308,826
-74% -$5.55M ﹤0.01% 3623
2014
Q4
$7.11M Sell
414,775
-26,113
-6% -$447K ﹤0.01% 2381
2014
Q3
$6.31M Buy
440,888
+152,182
+53% +$2.18M ﹤0.01% 2437
2014
Q2
$4.33M Sell
288,706
-68,065
-19% -$1.02M ﹤0.01% 2786
2014
Q1
$4.78M Buy
356,771
+266,679
+296% +$3.57M ﹤0.01% 2620
2013
Q4
$726K Sell
90,092
-19,038
-17% -$153K ﹤0.01% 4184
2013
Q3
$717K Sell
109,130
-4,477
-4% -$29.4K ﹤0.01% 4073
2013
Q2
$697K Buy
+113,607
New +$697K ﹤0.01% 4010